Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Muzaffar Kayumov

14 ta ish

Oʻzbekiston Respublikasi Fanlar Akademiyasi

AkademScholarda batafsil koʻrsatkichlar

  1. Toad venom bufadienolides and bufotoxins: An updated review

    Akmal M. Asrorov, Muzaffar Kayumov, Nurkhodja Mukhamedov +8

    Sharh maqolaIon Transport and Channel RegulationDrug Development Research20234 iqtibos
    ABI

  2. Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation

    Muzaffar Kayumov, Fotima A. Sobirova, Okhunjon Khasanov +3

    Sharh maqolaSesquiterpenes and Asteraceae StudiesNatural Product Research20253 iqtibos
    ABI

  3. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

    Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

    MaqolaPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 iqtibos
    ABI

  4. Synthesis and Characterisation of Chickpea Peptides-Zinc Chelates Having ACE2 Inhibitory Activity

    Nurkhodja Mukhamedov, Akmal M. Asrorov, Ansor Yashinov +5

    MaqolaProtein Hydrolysis and Bioactive PeptidesThe Protein Journal20231 iqtibos
    ABI

  5. Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy

    Akmal M. Asrorov, Nurkhodja Mukhamedov, Muzaffar Kayumov +5

    MaqolaOchiq kirishProtein Interaction Studies and Fluorescence AnalysisMedicine in Drug Discovery20241 iqtibos
    ABI

  6. Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition

    Muzaffar Kayumov, Parthiban Marimuthu, Jamoliddin Razzokov +8

    MaqolaOchiq kirishMedicinal Plant ResearchFrontiers in Pharmacology20251 iqtibos
    ABI

  7. 3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study

    Muzaffar Kayumov, Jamoliddin Razzokov, Mukhriddin Makhkamov +10

    MaqolaDrug-Induced Hepatotoxicity and ProtectionJournal of Computer-Aided Molecular Design20251 iqtibos
    ABI

  8. A new polymorphic form of 3b,11a,14-trihydroxy-5b,14b-bufa-20,22-dienolide (telocinobufagin) and its p300 and NNMT inhibitory activity

    Muzaffar Kayumov, Nurkhodja Mukhamedov, Jamshid Ashurov +8

    MaqolaSesquiterpenes and Asteraceae StudiesJournal of Molecular Structure20251 iqtibos
    ABI

  9. Synthesis of Arylstannanes via Palladium‐Catalyzed Decarbonylative Coupling of Aroyl Fluorides

    Muzaffar Kayumov, Jiannan Zhao, Sharafitdin Mirzaakhmedov +2

    MaqolaFluorine in Organic ChemistryAdvanced Synthesis & Catalysis20190 iqtibos
    ABI

  10. Food Protein‐Derived Zinc‐Binding Peptides: Isolation, Purification, and Biological Aspects

    Nurkhodja Mukhamedov, Akmal M. Asrorov, Muzaffar Kayumov +4

    MaqolaOchiq kirishProtein Hydrolysis and Bioactive PeptidesPeptide Science20240 iqtibos
    ABI

  11. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

    Qianqian Huang, Fan Tong, Jiantao Chen +5

    Sharh maqolaOchiq kirishNanoplatforms for cancer theranosticsAdvanced Science20250 iqtibos
    ABI

  12. Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

    Haoran Lu, Zixiao Yang, Muzaffar Kayumov +7

    MaqolaProtein Degradation and InhibitorsACS Nano20260 iqtibos
    ABI

  13. Design, Synthesis, In Vitro Evaluation, and Molecular Docking of 4‐Substituted Anilides as Histone Deacetylase Inhibitors and Potential Anticancer Agents

    Maryna Lisouskaya, Alesia Panibrat, Muzaffar Kayumov +3

    MaqolaOchiq kirish20260 iqtibos
    ABI

  14. Snake venom toxins in cancer therapy: advances in targeted delivery and peptide design

    Akmal M. Asrorov, Matluba Mirzaeva, Muzaffar Kayumov +7

    Sharh maqolaOchiq kirish20260 iqtibos
    ABI